Bionano Genomics Inc (NAS:BNGO)
$ 0.8588 0.0145 (1.72%) Market Cap: 59.35 Mil Enterprise Value: 43.68 Mil PE Ratio: 0 PB Ratio: 0.60 GF Score: 46/100

Bionano Genomics Inc Acquires Diagnostics Services Provider Lineagen Inc - M&A Call Transcript

Aug 24, 2020 / 12:30PM GMT
Release Date Price: $6.14 (-4.02%)
Operator

Hello and welcome to the Bionano Genomics Inc. conference call. (Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to turn the call over to your host, Monique Kosse with LifeSci Advisors. Please go ahead, Monique.

Monique Kosse
LifeSci Advisors, LLC - MD

Thank you, operator, and good morning, everyone. Welcome to the Bionano Genomics Conference Call. Leading the call today will be Dr. Erik Holmlin, CEO of Bionano. This morning, Bionano issued a press release announcing its acquisition of Lineagen. A copy of the release can be found on the Investor Relations page of the company's website.

Before we begin, I would like to remind everyone that certain statements made during this conference call may be forward-looking, including statements about Bionano strategic and commercialization plans, 2020 sales pipeline, anticipated benefits or improvements to the Saphyr System and advantages of the Saphyr System over current technologies, expectations regarding timing, assumptions regarding the COVID-19

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot